COTS Ocular TB Risk (Report 2)

Name: COTS Ocular TB Risk (Report 2)
Author: Liangbo Linus Shen, MD

Collaborative Ocular Tuberculosis Study (COTS) Report 2 consensus guidelines for initiating antitubercular therapy (ATT) in tubercular anterior uveitis, intermediate uveitis, panuveitis and retinal vasculitis. Choroiditis phenotypes are covered by COTS Report 1 and are not handled here.

References

Agrawal R et al.. Collaborative Ocular Tuberculosis Study Consensus Guidelines on the Management of Tubercular Uveitis-Report 2. Ophthalmology 2021.
Agrawal R et al.. Collaborative Ocular Tuberculosis Study Consensus Guidelines on the Management of Tubercular Uveitis-Report 1. Ophthalmology 2021.

This tool is for informational and educational purposes only and is not a substitute for professional medical judgment.